We believe that our recent cash and income equivalents readily available positions us to speed up our planning for going promptly into our pivotal research for our direct application MM-120 and we’ll be enough to fulfill our operating needs further than our important growth milestones in 2023 and into the very first 50 percent of 2025.The main wo… Read More